Article info

Download PDFPDF
Risk of malignancy in patients treated for systemic necrotising vasculitis

Authors

  1. Correspondence to Dr Antoine Lafarge, Internal Medicine, Hopital Cochin, Paris 75014, France; antoinelafarge{at}outlook.com; Pr Benjamin Terrier; benjamin.terrier{at}aphp.fr
View Full Text

Citation

Lafarge A, Joseph A, Pagnoux C on behalf of the French Vasculitis Study Group (FVSG), et al
Risk of malignancy in patients treated for systemic necrotising vasculitis

Publication history

  • Received October 9, 2019
  • Revised November 12, 2019
  • Accepted November 15, 2019
  • First published November 25, 2019.
Online issue publication 
February 12, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.